In the next step, the researchers want to develop new molecules based on digoxin that are even better at dissolving the CTC clusters.

Dividend stocks can be a great way to boost your portfolio's growth potential or provide a form of passive income over the ...

Katie Elson is not yet 30. In early 2022 her partner noticed a small lump in her breast. At first they thought it was an ...

This is not the first time lawmakers have pushed to change state laws requiring approval from insurance companies for receiving health care.

Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefited from first-line treatment with the targeted therapies encorafenib and cetuximab plus a mFOLFOX6 chemotherapy ...

More than Pink Walk brings in thousands of people for breast cancer awareness. A sea of pink filled the streets of Downtown ...

Pfizer Inc. today announced positive results from the Phase 3 BREAKWATER trial evaluating BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX®) and mFOLFOX6 (fluorouracil, ...

With a full-blown land war in Ukraine and an isolationist American president back in the White House, European leaders have come to a stark conclusion: They must spend more on their militaries ...

A Wall St. street sign is seen near the New York Stock Exchange (NYSE) in New York City, U.S., September 17, 2019. REUTERS/Brendan McDermid/File Photo The tepid reception to Venture Global's ...

Pete Hegseth Is Sworn In as Defense Secretary After Being Confirmed by Slim Margin Mr. Hegseth has vowed to bring his “warrior” ethos to the Pentagon. His confirmation came down to Vice ...

The 2-year benefit of bevacizumab in colorectal cancer may explain why survival benefits are seen in studies with two-year, ...

Whether you’re a fan of the All Blacks, a follower of the women’s game or someone who watches every phase of play in the Premiership, our rugby features and news pieces will provide you with all of ...